603718 *ST海利生物
按盤價 
3.340 -0.080 (-2.339%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.717 | -25.501 | 12.326 | 5.334 | 11.334 |
| 總資產報酬率 ROA (%) | 0.534 | -21.100 | 9.825 | 3.964 | 7.242 |
| 投入資產回報率 ROIC (%) | 0.601 | -23.855 | 11.854 | 5.051 | 10.793 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.676 | 72.172 | 60.204 | 51.394 | 58.969 |
| 營業利潤率 (%) | 19.406 | -310.558 | 64.391 | 22.919 | 23.309 |
| 息稅前利潤/營業總收入 (%) | 20.811 | -100.060 | 74.197 | 24.417 | 46.493 |
| 淨利潤/營業總收入 (%) | 16.871 | -155.512 | 67.014 | 20.776 | 36.898 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.783 | -26.042 | 14.352 | -12.366 | 6.497 |
| 價值變動淨收益/利潤總額(%) | 0.887 | -2.482 | 69.982 | 101.072 | 8.615 |
| 營業外收支淨額/利潤總額(%) | -0.506 | -215.688 | 16.140 | 1.521 | 46.711 | 償債能力分析 |
| 流動比率 (X) | 4.266 | 5.342 | 6.901 | 1.349 | 2.073 |
| 速動比率 (X) | 3.757 | 4.809 | 6.352 | 1.102 | 1.622 |
| 資產負債率 (%) | 25.053 | 20.366 | 6.768 | 29.133 | 26.630 |
| 帶息債務/全部投入資本 (%) | 8.227 | 1.386 | 0.843 | 0.619 | -2.041 |
| 股東權益/帶息債務 (%) | 984.299 | 6,278.160 | 11,585.741 | 15,234.977 | -4,661.548 |
| 股東權益/負債合計 (%) | 283.271 | 384.930 | 1,262.056 | 251.985 | 282.786 |
| 利息保障倍數 (X) | 13.852 | 59.389 | -28.674 | 21.344 | 16.889 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 207.522 | 200.502 | 128.418 | 136.280 | 112.325 |
| 存貨周轉天數 (天) | 349.178 | 394.100 | 263.391 | 381.076 | 420.438 |
| 備註： | 即時報價更新時間為 22/05/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
